Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Clinical trial NCT04074317 · COMPLETED

Trial details

NCT number: NCT04074317
Sponsor: Xeris Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Insulin-dependent Diabetes Mellitus

Start date: 2019-08-22
Primary completion: 2020-04-02
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.